View More Recent Stories
-
Waters Corp. (WAT) Tops Q1 EPS by 3c; raises guidance
-
KeyBanc Upgrades Waters Corp. (WAT) to Overweight
-
Baird Upgrades Waters Corp. (WAT) to Outperform
-
Stifel Reiterates Hold Rating on Waters Corp. (WAT)
-
TD Cowen on Waters Corp. (WAT): 'Impressive Showcase of Strategy, Execution, Growth & Margins'
-
Waters Corp. (WAT) PT Raised to $430 at Leerink Partners
-
Buy the earnings dip in this stock: Bernstein
-
Bernstein on Waters Corp. (WAT): 'Buy the Dip'
-
Waters Corp. (WAT) PT Lowered to $410 at BofA Securities
-
Waters Corp. (WAT) Tops Q4 EPS by 7c; offers guidance
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Waters Corp. (WAT) call put ratio 2 calls to 1 put as share price down 2.2%
-
Waters Corp. (WAT), Others Decline on Concerns about New Export Controls on Biotech Equipment
-
Bernstein SocGen Group Upgrades Waters Corp. (WAT) to Outperform
-
Waters Corp. (WAT) PT Raised to $410 at TD Cowen
-
Waters Corp. (WAT) Tops Q3 EPS by 25c, raises guidance
-
CFRA Upgrades Waters Corp. (WAT) to Buy (midday)
-
Citi Downgrades Bunzl Plc. (BNZL:LN) (BZLFY) to Neutral
-
JPMorgan Upgrades Bunzl Plc. (BNZL:LN) (BZLFY) to Overweight
-
Jefferies Upgrades Waters Corp. (WAT) to Buy
-
Waters Corp. (WAT) Appoints Heather Knight to its Board
-
Waters Corp. (WAT) PT Raised to $363 at TD Cowen
-
Waters Corp. (WAT) Tops Q2 EPS by 6c; updates guidance
-
10 policies if Trump wins and stock implications: Jefferies
-
Life Science Tools & Diagnostics stocks: Q2 earnings preview

